These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28558371)

  • 1. Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema.
    Veritti D; Sarao V; Galiazzo F; Lanzetta P
    Ophthalmologica; 2017; 238(1-2):100-105. PubMed ID: 28558371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
    Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid response to dexamethasone intravitreal implant in diabetic macular edema.
    Lo Giudice G; Avarello A; Campana G; Galan A
    Eur J Ophthalmol; 2018 Jan; 28(1):74-79. PubMed ID: 28708221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone Implants in Diabetic Macular Edema Patients with High Visual Acuity.
    Sacconi R; Battaglia Parodi M; Casati S; Lattanzio R; Marchini G; Bandello F
    Ophthalmic Res; 2017; 58(3):125-130. PubMed ID: 28704825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone for unresponsive diabetic macular oedema: optical coherence tomography biomarkers.
    Bonfiglio V; Reibaldi M; Pizzo A; Russo A; Macchi I; Faro G; Avitabile T; Longo A
    Acta Ophthalmol; 2019 Jun; 97(4):e540-e544. PubMed ID: 30318792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological and functional changes in recalcitrant diabetic macular oedema after intravitreal dexamethasone implant.
    Iacono P; Parodi MB; Scaramuzzi M; Bandello F
    Br J Ophthalmol; 2017 Jun; 101(6):791-795. PubMed ID: 27625164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
    Zur D; Iglicki M; Busch C; Invernizzi A; Mariussi M; Loewenstein A;
    Ophthalmology; 2018 Feb; 125(2):267-275. PubMed ID: 28935399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study.
    Fonollosa A; Zarranz-Ventura J; Valverde A; Becerra E; Bernal-Morales C; Pastor-Idoate S; Zapata MA
    Graefes Arch Clin Exp Ophthalmol; 2019 Nov; 257(11):2381-2390. PubMed ID: 31451909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated Dexamethasone Intravitreal Implant for the Treatment of Diabetic Macular Oedema Unresponsive to Anti-VEGF Therapy: Outcome and Predictive SD-OCT Features.
    Hatz K; Ebneter A; Tuerksever C; Pruente C; Zinkernagel M
    Ophthalmologica; 2018; 239(4):205-214. PubMed ID: 29402873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema.
    Cicinelli MV; Cavalleri M; Querques L; Rabiolo A; Bandello F; Querques G
    Br J Ophthalmol; 2017 Dec; 101(12):1689-1693. PubMed ID: 28432109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.
    Maturi RK; Glassman AR; Liu D; Beck RW; Bhavsar AR; Bressler NM; Jampol LM; Melia M; Punjabi OS; Salehi-Had H; Sun JK;
    JAMA Ophthalmol; 2018 Jan; 136(1):29-38. PubMed ID: 29127949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: six-month outcomes of the UDBASA study.
    Sarao V; Veritti D; Furino C; Giancipoli E; Alessio G; Boscia F; Lanzetta P
    Acta Ophthalmol; 2017 Jun; 95(4):e255-e260. PubMed ID: 28139100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema.
    Vujosevic S; Torresin T; Bini S; Convento E; Pilotto E; Parrozzani R; Midena E
    Acta Ophthalmol; 2017 Aug; 95(5):464-471. PubMed ID: 27775223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential Dexamethasone and Aflibercept Treatment in Patients with Diabetic Macular Edema: Structural and Functional Outcomes at 52 Weeks.
    Hernández-Bel L; Cervera-Taulet E; Navarro-Palop C; Castro-Navarro V; Chiarri-Toumit C; Montero-Hernández J
    Ophthalmologica; 2019; 241(2):98-104. PubMed ID: 29996128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of diabetic macular edema and factors predicting outcomes in sham-treated patients (MEAD study).
    Yoon YH; Boyer DS; Maturi RK; Bandello F; Belfort R; Augustin AJ; Li XY; Bai Z; Hashad Y;
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2639-2653. PubMed ID: 31654188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitrectomy Combined with Intraoperative Dexamethasone Implant for the Management of Refractory Diabetic Macular Edema.
    Kim KT; Jang JW; Kang SW; Chae JB; Cho K; Bae K
    Korean J Ophthalmol; 2019 Jun; 33(3):249-258. PubMed ID: 31179656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early effects of dexamethasone implant on macular morphology and visual function in patients with macular edema secondary to retinal vein occlusion.
    Veritti D; Macor S; Lanzetta P
    Ophthalmologica; 2014; 232(3):144-8. PubMed ID: 25300393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interval between Treatments of Bevacizumab and Dexamethasone Implants for Diabetic Macular Edema Increased over Time in the BEVORDEX Trial.
    Mehta H; Fraser-Bell S; Nguyen V; Lim LL; Gillies MC
    Ophthalmol Retina; 2018 Mar; 2(3):231-234. PubMed ID: 31047591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aqueous humour cytokine changes during a loading phase of intravitreal ranibizumab or dexamethasone implant in diabetic macular oedema.
    Podkowinski D; Orlowski-Wimmer E; Zlabinger G; Pollreisz A; Mursch-Edlmayr AS; Mariacher S; Ring M; Bolz M
    Acta Ophthalmol; 2020 Jun; 98(4):e407-e415. PubMed ID: 31736269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.
    Augustin AJ; Kuppermann BD; Lanzetta P; Loewenstein A; Li XY; Cui H; Hashad Y; Whitcup SM;
    BMC Ophthalmol; 2015 Oct; 15():150. PubMed ID: 26519345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.